An Open-Label, Multicenter, Phase I/II Study of Single-Agent AT-101 in Men with Castrate-Resistant Prostate Cancer (CRPC)

Por Liu, Glenn, Kelly, W Kevin, Wilding, George, Leopold, Lance, Brill, Kimberli, Somer, Bradley
Publicado em 2009